Cite
Mariz FC, Bender N, Anantharaman D, et al. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020;5(1):14doi: 10.1038/s41541-020-0165-x.
Mariz, F. C., Bender, N., Anantharaman, D., Basu, P., Bhatla, N., Pillai, M. R., Prabhu, P. R., Sankaranarayanan, R., Eriksson, T., Pawlita, M., Prager, K., Sehr, P., Waterboer, T., MĆ¼ller, M., & Lehtinen, M. (2020). Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ vaccines, 5(1), 14. https://doi.org/10.1038/s41541-020-0165-x
Mariz, Filipe ColaƧo, et al. "Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines." NPJ vaccines vol. 5,1 (2020): 14. doi: https://doi.org/10.1038/s41541-020-0165-x
Mariz FC, Bender N, Anantharaman D, Basu P, Bhatla N, Pillai MR, Prabhu PR, Sankaranarayanan R, Eriksson T, Pawlita M, Prager K, Sehr P, Waterboer T, MĆ¼ller M, Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5(1):14. doi: 10.1038/s41541-020-0165-x. eCollection 2020. PMID: 32128255; PMCID: PMC7021830.
Copy
Download .nbib